Tzu Chi Medical Journal
Volume 19, Issue 4 , Pages 207-219 , December 2007

Evidence-Based Review on Catheter-Related Thrombosis of the Implantable Venous Access Device

  • Chien-Yu Chen

      Affiliations

    • Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan
    • ,
  • Chih-Chung Liu

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Wei-Zen Sun

      Affiliations

    • Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Anesthesiology, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, Taiwan

Received 26 March 2007 ,Revised 4 April 2007 ,Accepted 15 May 2007.

References 

  1. Koonings PP , Given FT . Long-term experience with a totally implanted catheter system in gynecologic onco-logic patients . J Am Coll Surg . 1994;178:164–166
  2. Poorter RL , Lauw FN , Bemelman WA , Bakker PJ , Taat CW , Veenhof CH . Complications of an implantable venous access device (Port-a-Cath) during intermittent continu ous infusion of chemotherapy . Eur J Cancer . 1996;32A:2262–2266
  3. Lokich JJ , Bothe A , Benotti P , Moore C . Complications and management of implanted venous access catheters . J Clin Oncol . 1985;3:710–717
  4. Barrios CH , Zuke JE , Blaes B , Hirsch JD , Lyss AP . Evaluation of an implantable venous access system in a general oncology population . Oncology . 1992;49:474–478
  5. Kock HJ , Pietsch M , Krause U , Wilke H , Eigler FW . Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems . World J Surg . 1998;22:12–16
  6. Schwarz RE , Groeger JS , Coit DG . Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis . Cancer . 1997;79:1635–1640
  7. Centre for Evidence-based Medicine, Oxford, UK. Oxford Centre for Evidence-based Medicine Levels of Evidence . Available at: http://www.cebm.net/levels_of_evidence.asp#levels [Date accessed: May 2001]
  8. The Journal of Bone & Joint Surgery  . Levels of Evidence for Primary Research Question, Instructions to Authors . Available at: http://www2.ejbjs.org/misc/instrux.shtml
  9. Alhaddad IA , Soubani AO , Brown EJ , Jonas EA , Freeman I . Cardiogenic shock due to huge right atrial thrombus . Chest . 1993;104:1609–1610
  10. Kingdon EJ , Holt SG , Davar J , et al.   Atrial thrombus and central venous dialysis catheters . Am J Kidney Dis . 2001;38:631–639
  11. Forauer AR , Bocchini TP , Lucas ED , Parker KR . Giant right atrial thrombus: a life-threatening complication of long-term central venous access catheters . J Vasc Interv Radiol . 1998;9:519–520
  12. Korones DN , Buzzard CJ , Asselin BL , Harris JP . Right atrial thrombi in children with cancer and indwelling catheters . J Pediatr . 1996;128:841–846
  13. Gilon D , Schechter D , Rein AJ , et al.   Right atrial thrombi are related to indwelling central venous catheter position: insights into time course and possible mechanism of formation . Am Heart J . 1998;135:457–462
  14. Ozimek W , Wroblewska-Kaluzewska M , Gadomski A , et al.   Echocardiographic assessment of right atrial thrombus related to the implanted port device in patient receiving chemotherapy for non-Hodgkin's lymphoma . Med Sci Monit . 2000;6:1013–1017
  15. Ellis PK , Kidney DD , Deutsch LS . Giant right atrial thrombus: a life-threatening complication of long-term central venous access catheters . J Vasc Interv Radiol . 1997;8:865–868
  16. Cohen GI , Klein AL , Chan KL , Stewart WJ , Salcedo EE . Transesophageal echocardiographic diagnosis of right-sided cardiac masses in patients with central lines . Am J Cardiol . 1992;70:925–929
  17. Paut O , Kreitmann B , Silicani MA , et al.   Successful treatment of fungal right atrial thrombosis complicating central venous catheterization in a critically ill child . Intensive Care Med . 1992;18:375–376
  18. Horner SM , Bell JA , Swanton RH . Infected right atrial thrombus–an important but rare complication of central venous lines . Eur Heart J . 1993;14:138–140
  19. Kentos A , Dufaye P , Jacobs F , De Smet JM , Serruys E , Thys JP . Candida albicans septic thrombosis of the right atrium is associated with a central venous catheter . Clin Infect Dis . 1995;21:440–442
  20. Hollingsed MJ , Morales JM , Roughneen PT , Burch KD . Surgical management of catheter tip thrombus: surgical therapy for right atrial thrombus and fungal endocarditis (Candida tropicalis) complicating paediatric sickle-cell disease . Perfusion . 1997;12:197–201
  21. Gadomski A , Jaranowska D , Ebinger K , Ozimek W , Brzewski M . Right atrial thrombus complicating chemo-therapy by central venous catheterization in a child with Hodgkin's disease . Wiad Lek . 1998;51(Suppl 4):266–269
  22. Kroger K , Grutter R , Rudofsky G , Fink H , Niebel W . Follow-up after Port-a-Cath-induced thrombosis . J Clin Oncol . 2002;20:2605–2606
  23. Cobos E , Dixon S , Keung YK . Prevention and management of central venous catheter thrombosis . Curr Opin Hematol . 1998;5:355–359
  24. Glaser DW , Medeiros D , Rollins N , Buchanan GR . Catheter-related thrombosis in children with cancer . J Pediatr . 2001;138:255–259
  25. Pucheu A , Dierhas M , Leduc B , et al.   Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis . Bull Cancer . 1996;83:293–299
  26. Puel V , Caudry M , Le Metayer P , et al.   Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports . Cancer . 1993;72:2248–2252
  27. Kuriakose P , Colon-Otero G , Paz-Fumagalli R . Risk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective study . J Vasc Interv Radiol . 2002;13:179–184
  28. Rauthe G , Altmann C . Complications in connection with venous port systems: prevention and therapy . Eur J Surg Oncol . 1998;24:192–199
  29. Timoney JP , Malkin MG , Leone DM , et al.   Safe and cost effective use of alteplase for the clearance of occluded central venous access devices . J Clin Oncol . 2002;20:1918–1922
  30. Hooke C . Recombinant tissue plasminogen activator for central venous access device occlusion . J Pediatr Oncol Nurs . 2000;17:174–178
  31. Ponec D , Irwin D , Haire WD , Hill PA , Li X , McCluskey ER . Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial–the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial . J Vasc Interv Radiol . 2001;12:951–955
  32. Lawson M . Partial occlusion of indwelling central venous catheters . J Intraven Nurs . 1991;14:157–159
  33. Mayo DJ . Fibrin sheath formation and chemotherapy extravasation: a case report . Support Care Cancer . 1998;6:51–56
  34. Whigham CJ , Lindsey JI , Goodman CJ , Fisher RG . Venous port salvage utilizing low dose tPA . Cardiovasc Intervent Radiol . 2002;25:513–516
  35. Mehall JR , Saltzman DA , Jackson RJ , Smith SD . Fibrin sheath enhances central venous catheter infection . Crit Care Med . 2002;30:908–912
  36. Crowley JJ , Kenny A , Dardas P , Connolly DL , Shapiro LM . Identification of right atrial thrombi using transoesophageal echocardiography . Eur Heart J . 1995;16:708–710
  37. Oh WK , Lee BH , Sweitzer NK . Nonmalignant diagnoses in patients. Case 3. Right atrial thrombus associated with a central venous catheter in a patient with meta-static adrenocortical carcinoma . J Clin Oncol . 2000;18:2638–2639
  38. Schwartzbard AZ , Tunick PA , Rosenzweig BP , Kronzon I . The role of transesophageal echocardiography in the diagnosis and treatment of right atrial thrombi . J Am Soc Echocardiogr . 1999;12:64–69
  39. Jacobs BR , Haygood M , Hingl J . Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children . J Pediatr . 2001;139:593–596
  40. Davis SN , Vermeulen L , Banton J , Schwartz BS , Williams EC . Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices . Am J Health Syst Pharm . 2000;57:1039–1045
  41. Semba CP , Deitcher SR , Li X , Resnansky L , Tu T , McCluskey ER . Treatment of occluded central venous catheters with alteplase: results in 1,064 patients . J Vasc Interv Radiol . 2002;13:1199–1205
  42. Adamovich K , Tarnok A , Szauer E . Successful treatment of a right atrial thrombus secondary to central venous catheterization . Orv Hetil . 1999;140:1467–1470
  43. Cesaro S , Paris M , Corro R , et al.   Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin . Support Care Cancer . 2002;10:253–255
  44. Huraib S . Right atrial thrombus as a complication of subclavian vein catheterization–a case report . Angiology . 1992;43:439–442
  45. Wilimas JA , Hudson M , Rao B , Luo X , Lott L , Kaste SC . Late vascular occlusion of central lines in pediatric malignancies . Pediatrics . 1998;101:E7
  46. Ageno W , Huisman MV . Low-molecular-weight heparins in the treatment of venous thromboembolism . Curr Control Trials Cardiovasc Med . 2000;1:102–105
  47. Breddin HK , Hach-Wunderle V , Nakov R , Kakkar VV . Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis . N Engl J Med . 2001;344:626–631
  48. Hull RD , Raskob GE , Pineo GF , et al.   Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis . N Engl J Med . 1992;326:975–982
  49. Prandoni P , Lensing AW , Buller HR , et al.   Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis . Lancet . 1992;339:441–445
  50. Dolovich LR , Ginsberg JS , Douketis JD , Holbrook AM , Cheah G . A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency . Arch Intern Med . 2000;160:181–188
  51. Levine M , Gent M , Hirsh J , et al.   A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis . N Engl J Med . 1996;334:677–681
  52. Koopman MM , Prandoni P , Piovella F , et al.   Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group . N Engl J Med . 1996;334:682–687
  53. Levine M . Treatment of thrombotic disorders in cancer patients . Haemostasis . 1997;27(Suppl 1):38–43
  54. Haire WD , Atkinson JB , Stephens LC , Kotulak GD . Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial . Thromb Haemost . 1994;72:543–547
  55. Atkinson JB , Bagnall HA , Gomperts E . Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters . JPEN J Parenter Enteral Nutr . 1990;14:310–311
  56. Chesler L , Feusner JH . Use of tissue plasminogen activator (rt-PA) in young children with cancer and dysfunctional central venous catheters . J Pediatr Hematol Oncol . 2002;24:653–656
  57. Kleta R , Schleef J , Jurgens H . Tissue plasminogen activator and obstructed central venous catheters . Med Pediatr Oncol . 1998;30:376
  58. Food and Drug Administration  . FDA Talk Paper: Serious Manufacturing Deficiencies with Abbokinase Prompt FDA Letter to Abbott Labs. Rockville FL, MD: FDA . Available at: http://www.fda.gov/bbs/topics/ANSWERS/ANS00964.html [Date accessed: July 16, 1999]
  59. Neil G . Important Safety Information. VP Clinical Research, AstraZeneca, 1999 . Available at: http://www.fda.gov/medwatch/safety/1999/strept.htm
  60. Roberts S , Johnson M , Davies S . Near-fatal air embolism: fibrin sheath as the portal of air entry . South Med J . 2003;96:1036–1038

PII: S1016-3190(10)60018-3

doi: 10.1016/S1016-3190(10)60018-3

Tzu Chi Medical Journal
Volume 19, Issue 4 , Pages 207-219 , December 2007

Article Tools